Research Paper Volume 15, Issue 6 pp 2033—2045
Epimedin C protects dexamethasone-induced osteoblasts through NRF1/RhoA pathway
Figure 4. Epimedin C antagonizes the effects of DXMS. (A) Transient expression assay. Reporter Luc drive by RhoA promoter. (B) DLR assay with treatment of DXMS and/or Epimedin C. (C) IF staining for the endogenous RhoA in rodent long bone slice.